Pfizer opens study of COVID-19 shots updated to match omicron
Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant.
Stay updated with breaking news from B Biontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant.
The U.S. is urging that everyone 12 and older get a COVID-19 booster as soon as they're eligible, to help fight back the hugely contagious omicron mutant that's ripping through the country.
The U.S. is urging that everyone 12 and older get a COVID-19 booster as soon as they're eligible, to help fight back the hugely contagious omicron mutant that's ripping through the country.
The Food and Drug Administration on Monday cleared booster shots from Pfizer-BioNTech for Americans ages 12 to 15 and allowed people to get booster shots sooner, pointing to the omicron surge as the reason.
The Food and Drug Administration on Monday cleared booster shots from Pfizer-BioNTech for Americans ages 12 to 15 and allowed people to get booster shots sooner, pointing to the omicron surge as the reason.